EMD-18149
GBP1 bound by 14-3-3sigma
EMD-18149
Single-particle5.12 Å
Deposition: 07/08/2023Map released: 11/10/2023
Last modified: 18/10/2023
Sample Organism:
Homo sapiens
Sample: GBP1 bound by 14-3-3sigma
Fitted models: 8q4l
Deposition Authors: Pfleiderer MM
,
Liu X,
Fisch D ,
Anastasakou E ,
Frickel EM ,
Galej WP
Sample: GBP1 bound by 14-3-3sigma
Fitted models: 8q4l
Deposition Authors: Pfleiderer MM
,
Liu X,
Fisch D ,
Anastasakou E ,
Frickel EM ,
Galej WP
PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection.
Fisch D ,
Pfleiderer MM ,
Anastasakou E ,
Mackie GM ,
Wendt F ,
Liu X,
Clough B ,
Lara-Reyna S ,
Encheva V,
Snijders AP ,
Bando H,
Yamamoto M ,
Beggs AD ,
Mercer J,
Shenoy AR ,
Wollscheid B ,
Maslowski KM ,
Galej WP ,
Frickel EM
(2023) Science , 382 , eadg2253 - eadg2253
,
Pfleiderer MM ,
Anastasakou E ,
Mackie GM ,
Wendt F ,
Liu X,
Clough B ,
Lara-Reyna S ,
Encheva V,
Snijders AP ,
Bando H,
Yamamoto M ,
Beggs AD ,
Mercer J,
Shenoy AR ,
Wollscheid B ,
Maslowski KM ,
Galej WP ,
Frickel EM
(2023) Science , 382 , eadg2253 - eadg2253
Grant Support:
- Boehringer Ingelheim Fonds (BIF): (Germany)
- Human Frontier Science Program (HFSP): LT0006/2022-L (France)
- European Molecular Biology Organization (EMBO): ALTF 491-2022 (European Union)
- Wellcome Trust: 217202/Z/19/Z (United Kingdom)
- Medical Research Council (MRC, United Kingdom): MR/V030930/1 (United Kingdom)
- Medical Research Council (MRC, United Kingdom): MR/T029323/1 (United Kingdom)
- Wellcome Trust: FC001076 (United Kingdom)
- Medical Research Council (MRC, United Kingdom): FC001076 (United Kingdom)
- Cancer Research UK: FC001076 (United Kingdom)